The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

+90 850 321 50 00

Lung Cancer Screening — Low-Dose CT

Annual low-dose computed tomography (LDCT) screening in high-risk individuals (50-80 years, 20+ pack-year smoking history) reduces lung cancer mortality by 20% through early detection per USPSTF and NCCN guidelines.

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Göğüs Hastalıkları department. Book Appointment →

What is Lung Cancer Screening — Low-Dose CT?

Lung cancer screening with annual low-dose computed tomography (LDCT) in high-risk individuals reduces lung cancer mortality by detecting early-stage disease before symptom onset. Two landmark trials demonstrated mortality benefit: National Lung Screening Trial (NLST) showed 20% relative reduction in lung cancer mortality and 6.7% reduction in all-cause mortality with LDCT vs chest radiography; Dutch-Belgian NELSON trial confirmed 24% reduction in lung cancer mortality in men, 33% in women.

USPSTF 2021 guidelines recommend annual LDCT screening for adults aged 50-80 years with 20 or more pack-year smoking history who currently smoke or have quit within the past 15 years. Screening continues until age 80, smoker has not smoked for 15 years, or develops health problem limiting life expectancy or willingness for curative lung surgery. Eligibility expansion from previous 30 pack-year/age 55 criteria addresses disparities.

Lung-RADS (Lung Imaging Reporting and Data System) standardizes reporting and management of pulmonary nodules detected on LDCT. Categories 1-2 (negative/benign) require routine annual screening; category 3 (probably benign) requires 6-month follow-up LDCT; category 4 (suspicious) requires further evaluation with PET-CT, biopsy, or surgical consultation. Integration with smoking cessation counseling, comorbidity assessment, and multidisciplinary lung nodule clinics optimizes screening program effectiveness.

Symptoms

Asymptomatic at screening (early detection is the goal)
Persistent cough or change in chronic cough character
Hemoptysis (blood in sputum)
Unexplained weight loss
Persistent chest pain
Recurrent pneumonia in same lung area
Hoarseness or new shortness of breath in smoker

Risk Factors

Cigarette smoking (current or former, 20+ pack-years)
Age 50-80 years (USPSTF eligibility)
Quit smoking within past 15 years (still at elevated risk)
Family history of lung cancer (first-degree relative)
Radon exposure (second leading cause of lung cancer)
Occupational exposures: asbestos, silica, diesel exhaust, arsenic, chromium
Personal history of cancer (especially head/neck, esophageal)

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • Adults 50-80 years old with 20+ pack-year smoking history
  • Current smoker or quit within past 15 years
  • Discussion of screening benefits vs harms (shared decision-making)
  • Smoking cessation counseling (essential component of screening)
  • Family history of lung cancer in non-smokers (individualized assessment)
  • Symptoms suggesting lung cancer (urgent evaluation, not screening)
  • Abnormal chest imaging requiring nodule evaluation

Treatment Methods

01
Eligibility assessment: age, smoking history, quit time, life expectancy, willingness for curative treatment, shared decision-making discussion
02
Annual LDCT chest with low radiation dose (1.5 mSv vs 7-8 mSv standard CT)
03
Lung-RADS classification: 1-2 routine annual screening, 3 short-interval follow-up, 4A diagnostic LDCT or PET-CT, 4B/4X tissue diagnosis
04
Integrated smoking cessation counseling and pharmacotherapy at every screening visit
05
Multidisciplinary lung nodule evaluation: pulmonary, thoracic surgery, radiology, oncology
06
Diagnostic workup for suspicious nodules: PET-CT, EBUS-guided biopsy, CT-guided biopsy, navigational bronchoscopy
07
Treatment for diagnosed early-stage lung cancer: surgical resection (lobectomy preferred), stereotactic body radiation therapy (SBRT) for non-surgical candidates, multidisciplinary cancer care

Which Department to Visit?

You can visit our Göğüs Hastalıkları department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Göğüs Hastalıkları Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Book AppointmentContact Us

Related Health Topics

Other articles from the same department you may want to explore.

Asthma

Göğüs Hastalıkları

Asthma is characterized by wheezing, coughing and shortness of breath attacks; with proper treatment it can be kept under control.

COPD (Chronic Obstructive Pulmonary Disease)

Göğüs Hastalıkları

COPD is an irreversible lung disease characterized by shortness of breath and chronic cough; quitting smoking slows its progression.

Pneumonia

Göğüs Hastalıkları

Pneumonia presents with high fever, cough and shortness of breath; the vast majority recover with appropriate antibiotic treatment.

Tuberculosis (TB)

Göğüs Hastalıkları

Tuberculosis presents with weeks-to-months of cough, fever, and night sweats; early diagnosis and treatment lead to full recovery.

Pleural Effusion

Göğüs Hastalıkları

Pleural effusion is the accumulation of excess fluid in the pleural space, resulting from imbalances in fluid production and removal, and represents a manifestation of diverse cardiopulmonary, infectious, and malignant disorders.

Pneumothorax

Göğüs Hastalıkları

Pneumothorax is the presence of air in the pleural space resulting in partial or complete lung collapse, classified as spontaneous (primary/secondary), traumatic, or iatrogenic, with tension pneumothorax representing a life-threatening emergency.

Bronchitis (Acute and Chronic)

Göğüs Hastalıkları

Acute bronchitis is mostly viral and resolves spontaneously, while chronic bronchitis is a smoking-related component of COPD.

Bronchiectasis

Göğüs Hastalıkları

Bronchiectasis is a chronic respiratory disease characterized by permanent, abnormal dilation of bronchi with associated destruction of muscular and elastic components of airway walls, resulting in impaired mucociliary clearance and recurrent infection.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.